Bristol-Myers Squibb CompanyBMYNYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank64
3Y CAGR-7.5%
5Y CAGR-5.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-7.5%/yr
vs +32.0%/yr prior
5Y CAGR
-5.6%/yr
Consistent
Acceleration
-39.4pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $15.59B | -25.3% |
| 2024 | $20.87B | +6.2% |
| 2023 | $19.65B | -0.1% |
| 2022 | $19.67B | +0.2% |
| 2021 | $19.62B | -5.7% |
| 2020 | $20.82B | +134.0% |
| 2019 | $8.89B | +37.1% |
| 2018 | $6.49B | +11.5% |
| 2017 | $5.82B | +18.0% |
| 2016 | $4.93B | - |